Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-633-5 | CAS number: 123-51-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 20 March 1997 - 09 Sept 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Remarks:
- Institute of Toxicology, Merck KGaA
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 3-methylbutan-1-ol
- EC Number:
- 204-633-5
- EC Name:
- 3-methylbutan-1-ol
- Cas Number:
- 123-51-3
- Molecular formula:
- C5H12O
- IUPAC Name:
- 3-methylbutan-1-ol
- Details on test material:
- - Name of test material (as cited in study report): 3-Methylbutanol-1 (BG-Nr. 95), Isoamylalkohol
- Lot/batch No.: S18054
- Analytical purity: 99.7 % (GC)
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH
- Age at study initiation: 8 weeks
- Weight at study initiation: mean 35 g (males), 26 g (females)
- Assigned to test groups randomly: yes, under following basis: provided by the SAS program TXS750 developed by Corporate Biometrics, Merck
KGaA, Darmstadt
- Housing: individually in Makrolon cages type 1(floor area: 21 x 10 cm, height: 13 cm) on softwood chippings
- Diet (e.g. ad libitum): Altromin standard diet TPFR N 1324 (10 mm pellets, poor in nitrosamines) from Altromin; ad libitum
- Water (e.g. ad libitum): tap water from Makrolon drinking bottles (water source: Südhessische Gas- und Wasser AG, Darmstadt, Germany and waterworks Merck KGaA, Weiterstadt, Germany); ad libitum
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 23
- Humidity (%): 58 - 74
- Atmospheric pressure: 761 - 762.5 mm Hg
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: To:
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: 0.25% aqueous Methocel K4M premium
- Concentration of test material in vehicle: 150 mg/ml
- Amount of vehicle (if gavage): 10 ml - Details on exposure:
- Dose selection rationale:
The highest 3-Methylbutanol-1 (BG-Nr. 95) dose given in the present study was selected to produce signs of toxicity but no mortality. In preliminary dose-finding experiments, 2 male and 2 female mice treated orally with 1500 mg 3-Methylbutanol-1 (BG-Nr. 95) / kg bw, showed clear toxic effects ( dyspnea, prone position, titubation and a loss in body weight) but no mortality. At the next higher dose (2000 mg/kg bw) extremly strong and at the next lower dose (1000 mg/kg bw) only weak toxic symptoms were detected. For these reasons, the dose of 1500 mg 3-Methylbutanol-1 (BG-Nr. 95) / kg bw was selected as the highest dose for both, the male and female mice in the main study of this investigation. - Duration of treatment / exposure:
- single
- Frequency of treatment:
- once
- Post exposure period:
- 24 and 48 hours, respectively
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1500 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: oral
- Doses / concentrations: 19.75 mg/kg bw
Examinations
- Tissues and cell types examined:
- Bone marrow erythrocytes from 2 femurs of each animal
- Details of tissue and slide preparation:
- SAMPLING TIME (in addition to information in specific fields): 24 and 48 hours after administration of the test substance, respectively. For the positive and negative control groups, the preparation time was 24 hours after start of the treatment.
DETAILS OF SLIDE PREPARATION:
Bone marrow smears were stained with Giemsa's solution. For microscopic investigation one slide from each animal preparation was coded.
METHOD OF ANALYSIS:
The number of polychromatic erythrocytes with micronuclei per 2000 polychromatic erythrocytes per animal was determined. The quotient of normochromatic to polychromatic erythrocytes was calculated based on the analysis of 1000 erythrocytes per animal. The micronucleated normochromatic erythrocytes were registered when scoring the polychromatic erythrocytes. The number of micronucleated normochromatic erythrocytes per 1000 erythrocytes was then calculated with the aid of the quotient. - Evaluation criteria:
- A test material is defined as mutagenic in this system if dose-related or single, reproducible (in independent experiments) positive effects occur. Establishment of dose-dependent effects of the test material is deemed preferable.
- Statistics:
- Pairwise comparison:
Each treatment group was compared to the negative control. For comparisons the exact Fisher-Pitman permutation test (Leimer, 1991) was used against onesided alternatives.
Multiple test procedure:
As there was more than one treatment group, the p-values were considered jointly to maintain an error rate (multiple level of significance) of a = 5 %. For this purpose the Bonferroni-Holm multiple test procedure was used (Holm, 1979). The positive control (cyclophosphamide) was not included in Holm's procedure. It was compared with the control separately at a level of 5 %.
Leimer I, Peil H and Ellenberger J (1991). Statistical Analysis of the Micronucleus Test with the Fisher-Pitman Permutation Test. In: Hothorn L., ed., Statistical Methods in Toxicology, Springer, 20 - 24.
Holm S (1979). A simple sequentially rejective multiple test procedure. Scand. J. Statist. 6: 65 - 70.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- In a preceding range finding test with 2 male and 2 female mice, the dose of 1500 mg/kg bw was severely toxic, however, no mortality occurred.
- Vehicle controls validity:
- valid
- Negative controls validity:
- other: The negative control (solvent) values were all in or very close to the expected range predetermined as historical controls of the laboratory.
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
- Ratio of PCE/NCE (for Micronucleus assay): No relevant treatment-related variation was observed.
- Clinical signs of toxicity: At 1500 mg/kg bw the following clinical signs were noted: dyspnoea (16/20), prone position (15/20) and titubation (5/20). The animals of the solvent control group showed no abnormalities.
- Body weight: A relevant treatment-related decrease in body weight was observed at the 3-Methylbutanol-1 (BG-Nr. 95) doses tested in male and female animals.
Any other information on results incl. tables
48 hours after administration of the test material, no significant increase in the micronucleus frequency has been detected in the main study as compared to the negative control group. 24 hours after start of the treatment, no increase in the micronucleus frequency was seen in the male group either. Micronucleus frequency of the 24 hour female group was weakly (0.17 % cells with micronuclei, negative control: 0.05 %) and statistically significantly (p = 0.02) increased.
The obtained mean numbers of polychromatic erythrocytes with micronuclei per 1000 PCE (MN-PCE) are presented below:
Group |
MN-PCE (%) in males |
MN-PCE (%) in females |
A |
0.08 |
0.05 |
B |
0.15 |
0.17 (p0.05) |
C |
0.18 |
0.08 |
D |
0.99 (p0.01) |
0.77 (p0.01) |
For the number of normochromatic cells with micronuclei, no increase was observed.
Since the observed positive effect in the female animals (24 hrs) was only minimal, it was considered to be not relevant.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.